Sistema de Salut de Catalunya
Institut Català de la Salut
[Rodríguez-Lescure A] Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain. [de la Peña FA] Haematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain. [Aranda E] Oncology Department, Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Madrid, Spain. [Calvo A] Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain. [Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Garrido P] Medical Oncology Department, Hospital Universitario Ramón Y Cajal, Madrid, Spain
Vall d'Hebron Barcelona Hospital Campus
2021-09-23T10:56:28Z
2021-09-23T10:56:28Z
2020-12
Biomarcador; Medicament; Oncologia
Biomarker; Drug; Oncology
Biomarcador; Medicamento; Oncología
Purpose The Spanish Society of Medical Oncology (SEOM) has carried out a study to analyse the conditions of access to oncology drugs in clinical practice in Spain. For the first time, the access of predictive biomarkers has also been analyzed. Methods A questionnaire was sent to 146 hospitals in Spain to collect information on the process of approval of 11 oncology drugs of an unquestionable clinical benefit and five predictive biomarkers of mandatory determination for specific treatments. Results Results highlight the still existing differences in the access of oncology drugs, as well as the newly identified differences in the access to predictive biomarkers between Autonomous Communities (AACC) in Spain, as well as between different hospitals within the same Autonomous Community. Conclusions The SEOM considers it necessary to reduce the differences identified, increase homogeneity, and improve conditions of access to oncology drugs and biomarkers, and makes proposals to address these issues.
This study was funded by SEOM.
Article
Published version
English
Marcadors tumorals; Medicaments - Desenvolupament; Oncologia; CHEMICALS AND DRUGS::Biological Factors::Biomarkers::Biomarkers, Tumor; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Drug Development::Drug Approval; DISCIPLINES AND OCCUPATIONS::Health Occupations::Medicine::Internal Medicine::Medical Oncology; COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores::marcadores tumorales; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::desarrollo de medicamentos::autorización de medicamentos; DISCIPLINAS Y OCUPACIONES::profesiones sanitarias::medicina::medicina interna::oncología médica
Springer
Clinical and Translational Oncology;22
https://doi.org/10.1007/s12094-020-02366-y
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3437]
